my timesThe Korea Times

SK Bioscience swings to loss in Q2

Listen
  • Published KST
  • Updated KST

SK Bioscience's vaccine factory in Andong, North Gyeongsang Province / Courtesy of SK Bioscience

SK Bioscience on Friday reported its second-quarter net loss of 16 billion won ($12.5 million), swinging from a profit of 46.1 billion won a year earlier.

The company said in a regulatory filing that it posted an operating loss of 35.3 billion won for the April-June period, compared with a profit of 61.2 billion won a year ago. Revenue fell 80.9 percent to 26.5 billion won.

The operating loss was 25.1 percent higher than the average estimate, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency. (Yonhap)